Combination of static magnetic field and cisplatin in order to reduce drug resistance in cancer cell lines

References

• Abercrombie M, Ambrose E. 1962. The surface properties of cancer cells: a review. Cancer Res. 22:525–548.
   PubMed Web of Science ®Google Scholar
• Aldinucci C, Garcia JB, Palmi M, Sgaragli G, Benocci A, Meini A, Pessina F, Rossi C, Bonechi C, Pessina GP. 2003. The effect of strong static magnetic field on lymphocytes. Bioelectromagnetics. 24:109–117.
   PubMed Web of Science ®Google Scholar
• Basu A, Tu H. 2005. Activation of ERK during DNA damage-induced apoptosis involves protein kinase Cδ. Biochem Biophys Res Commun. 334:1068–1073.
   PubMed Web of Science ®Google Scholar
• Bersani F, Marinelli F, Ognibene A, Matteucci A, Cecchi S, Santi S, Squarzoni S, Maraldi NM. 1997. Intramembrane protein distribution in cell cultures is affected by 50 Hz pulsed magnetic fields. Bioelectromagnetics. 18:463–469.
   PubMed Web of Science ®Google Scholar
• Bodo J, Chovancova J, Hunakova L, Sedlak J. 2005. Enhanced sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to the combination of cisplatin and synthetic isothiocyanate ethyl 4-isothiocyanatobutanoate. Neoplasma. 52:510.
   PubMed Web of Science ®Google Scholar
• Bordiushkov I, Goroshinskaia I, Frantsiiants E, Tkacheva G, Gorlo E, Neskubina I. 2000. Structural-functional changes in lymphocyte ans erythrocyte membranes after exposure to alternating magnetic field. Voprosy Medit͡Sinskoĭ Khimii. 46:72.
   PubMed Web of Science ®Google Scholar
• Brozovic A, Ambriović-Ristov A, Osmak M. 2010. The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin. Crit Rev Toxicol. 40:347–359.
   PubMed Web of Science ®Google Scholar
• Brozovic A, Osmak M. 2007. Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance. Cancer Lett. 251:1–16.
   PubMed Web of Science ®Google Scholar
• Chaney SG, Campbell SL, Bassett E, Wu Y. 2005. Recognition and processing of cisplatin- and oxaliplatin-DNA adducts. Crit Rev Oncol Hematol. 53:3–11.
   PubMed Web of Science ®Google Scholar
• Chen W-F, Qi H, Sun R-G, Liu Y, Zhang K, Liu J-Q. 2010. Static magnetic fields enhanced the potency of cisplatin on k562 cells. Cancer Biother Radiopharm. 25:401–408.
   PubMed Web of Science ®Google Scholar
• Chionna A, Dwikat M, Panzarini E, Tenuzzo B, Carla E, Verri T, Pagliara P, Abbro L, Dini L. 2003. Cell shape and plasma membrane alterations after static magnetic fields exposure. Eur J Histochem. 47:299.
   PubMed Web of Science ®Google Scholar
• Chionna A, Tenuzzo B, Panzarini E, Dwikat MB, Abbro L, Dini L. 2005. Time dependent modifications of Hep G2 cells during exposure to static magnetic fields. Bioelectromagnetics. 26:275–286.
   PubMed Web of Science ®Google Scholar
• Dasari S, Tchounwou PB. 2014. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 740:364–378.
   PubMed Web of Science ®Google Scholar
• Fanelli C, Coppola S, Barone R, Colussi C, Gualandi G, Volpe P, Ghibelli L. 1999. Magnetic fields increase cell survival by inhibiting apoptosis via modulation of Ca2+ influx. FASEB J. 13:95–102.
   PubMed Web of Science ®Google Scholar
• Florea A-M, Büsselberg D. 2009. Anti-cancer drugs interfere with intracellular calcium signaling. Neurotoxicology. 30:803–810.
   PubMed Web of Science ®Google Scholar
• Fotakis G, Timbrell JA. 2006. In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicology Lett. 160:171–177.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M, Kroemer G. 2012. Molecular mechanisms of cisplatin resistance. Oncogene. 31:1869.
   PubMed Web of Science ®Google Scholar
• Ghezzi A, Aceto M, Cassino C, Gabano E, Osella D. 2004. Uptake of antitumor platinum (II)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS). J Inorg Biochem. 98:78–78.
   Google Scholar
• Hao Q, Wenfang C, Xia A, Qiang W, Ying L, Kun Z, Runguang S. 2011. Effects of a moderate‐intensity static magnetic field and adriamycin on K562 cells. Bioelectromagnetics. 32:191–199.
   PubMed Web of Science ®Google Scholar
• Javani Jouni F, Abdolmaleki P, Behmanesh M, Movahedin M. 2014. An in vitro study of the impact of 4mT static magnetic field to modify the differentiation rate of rat bone marrow stem cells into primordial germ cells. Differentiation. 87:230–237.
   PubMed Web of Science ®Google Scholar
• Kuo MT, Fu S, Savaraj N, Chen HH. 2012. Role of the human high-affinity copper transporter in copper homeostasis regulation and cisplatin sensitivity in cancer chemotherapy. Cancer Res. 72:4616–4621.
   PubMed Web of Science ®Google Scholar
• Manosroi J, Boonpisuttinant K, Manosroi W, Manosroi A. 2012. Anti-proliferative activities on HeLa cancer cell line of Thai medicinal plant recipes selected from MANOSROI II database. J Ethnopharmacol. 142:422–431.
   PubMed Web of Science ®Google Scholar
• Markov MS. 2010. Angiogenesis, magnetic fields and 'window effects'. Cardiology. 117:54–56.
   PubMed Web of Science ®Google Scholar
• Molnar J, Engi H, Hohmann J, Molnar P, Deli J, Wesolowska O, Michalak K, Wang Q. 2010. Reversal of multidrug resistance by natural substances from plants. Ctmc. 10:1757–1768.
   Google Scholar
• Nikounezhad N, Nakhjavani M, Shirazi FH. 2016. Generation of cisplatin-resistant ovarian cancer cell lines. Iran J Pharm Sci. 12:11–20.
   Google Scholar
• Nikounezhad N, Nakhjavani M, Shirazi FH. 2017. Cellular glutathione level does not predict ovarian cancer cells' resistance after initial or repeated exposure to cisplatin. J Exp Ther Oncol. 12:1.
   PubMed Web of Science ®Google Scholar
• Onodera H, Jin Z, Chida S, Suzuki Y, Tago H, Itoyama Y. 2003. Effects of 10-T static magnetic field on human peripheral blood immune cells. Radiat Res. 159:775–779.
   PubMed Web of Science ®Google Scholar
• Pacini S, Gulisano M, Peruzzi B, Sgambati E, Gheri G, Bryk SG, Vannucchi S, Polli G, Ruggiero M. 2003. Effects of 0.2 T static magnetic field on human skin fibroblasts. Cancer Detect Prev. 27:327–332.
   PubMedGoogle Scholar
• Paradisi S, Donelli G, Santini MT, Straface E, Malorni W. 1993. A 50‐Hz magnetic field induces structural and biophysical changes in membranes. Bioelectromagnetics. 14:247–255.
   PubMed Web of Science ®Google Scholar
• Pierre TGS, Dobson J. 2000. Theoretical evaluation of cell membrane ion channel activation by applied magnetic fields. Eur Biophys J. 29:455–456.
   PubMed Web of Science ®Google Scholar
• Rabik CA, Dolan ME. 2007. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treatment Rev. 33:9–23.
   PubMed Web of Science ®Google Scholar
• Rosen AD. 2003a. Effect of a 125 mT static magnetic field on the kinetics of voltage activated Na + channels in GH3 cells. Bioelectromagnetics. 24:517–523.
   PubMed Web of Science ®Google Scholar
• Rosen AD. 2003b. Mechanism of action of moderate-intensity static magnetic fields on biological systems. Cell Biochem Biophys. 39:163–173.
   PubMed Web of Science ®Google Scholar
• Sabo J, Mirossay L, Horovcak L, Sarissky M, Mirossay A, Mojzis J. 2002. Effects of static magnetic field on human leukemic cell line HL-60. Bioelectrochemistry. 56:227–231.
   PubMed Web of Science ®Google Scholar
• Sakurai H, Okuno K, Kubo A, Nakamura K, Shoda M. 1999. Effect of a 7-tesla homogeneous magnetic field on mammalian cells. Bioelectrochem Bioenerg. 49:57–63.
   PubMed Web of Science ®Google Scholar
• Shen D-W, Pouliot LM, Hall MD, Gottesman MM. 2012. Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol Rev. 64:706–721.
   PubMed Web of Science ®Google Scholar
• Siddik ZH. 2003. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 22:7265.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. 2015. Cancer statistics, 2015. Cancer J Clin. 65:5–29.
   PubMed Web of Science ®Google Scholar
• Somosy Z. 2000. Radiation response of cell organelles. Micron. 31:165–181.
   PubMed Web of Science ®Google Scholar
• Stewart DJ. 2007. Mechanisms of resistance to cisplatin and carboplatin. Crit Rev Oncol Hematol. 63:12–31.
   PubMed Web of Science ®Google Scholar
• Sullivan EJ, Kurtoglu M, Brenneman R, Liu H, Lampidis TJ. 2014. Targeting cisplatin-resistant human tumor cells with metabolic inhibitors. Cancer Chemother Pharmacol. 73:417–427.
   PubMed Web of Science ®Google Scholar
• Tatarov I, Panda A, Petkov D, Kolappaswamy K, Thompson K, Kavirayani A, Lipsky MM, Elson E, Davis CC, Martin SS. 2011. Effect of magnetic fields on tumor growth and viability. Comparat Med. 61:339.
   PubMed Web of Science ®Google Scholar
• Teodori L, Göhde W, Valente MG, Tagliaferri F, Coletti D, Perniconi B, Bergamaschi A, Cerella C, Ghibelli L. 2002. Static magnetic fields affect calcium fluxes and inhibit stress‐induced apoptosis in human glioblastoma cells. Cytometry. 49:143–149.
   PubMedGoogle Scholar
• Tofani S, Barone D, Berardelli M, Berno E, Cintorino M, Foglia L, Ossola P, Ronchetto F, Toso E, Eandi M. 2003. Static and ELF magnetic fields enhance the in vivo anti-tumor efficacy of cis-platin against lewis lung carcinoma, but not of cyclophosphamide against B16 melanotic melanoma. Pharmacol Res. 48:83–90.
   PubMed Web of Science ®Google Scholar
• Verdom BH, Abdolmaleki P, Behmanesh M. 2018. The static magnetic field remotely boosts the efficiency of doxorubicin through modulating ROS behaviors. Sci Rep. 8:990.
   PubMed Web of Science ®Google Scholar
• Wasenius VM, Jekunen A, Monni O, Joensuu H, Aebi S, Howell SB, Knuutila S. 1997. Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cells. Genes Chromosom Cancer. 18:286–291.
   PubMed Web of Science ®Google Scholar
• Williams CD, Markov MS, Hardman WE, Cameron IL. 2001. Therapeutic electromagnetic field effects on angiogenesis and tumor growth. Anticancer Res. 21:3887–3891.
   Google Scholar
• Wiskirchen J, Grönewäller EF, Heinzelmann F, Kehlbach R, Rodegerdts E, Wittau M, Rodemann HP, Claussen CD, Duda SH. 2000. Human fetal lung fibroblasts: in vitro study of repetitive magnetic field exposure at 0.2, 1.0, and 1.5 T 1. Radiology. 215:858–862.
   PubMed Web of Science ®Google Scholar
• Zafari J, Javani Jouni F, Abdolmaleki P, Jalali A, Khodayar M. 2015. Investigation on the effect of static magnetic field up to 30 mT on viability percent, proliferation rate and IC50 of HeLa and fibroblast cells. Electromagn Biol Med. 34:50–54.
   Web of Science ®Google Scholar
• Zafari J, Javani Jouni F, Jalali A, Javad Khodayar M, Abdolmaleki P. 2015. Investidation on the effect of magnetic static fieldon cancer and normal cell lines. Bulgarian J Pub Health. 7:152–155.
   Google Scholar